NEW YORK, Nov 12 (Reuters) - The U.S. Food and Drug Administration can approve new personalized treatments for rare and deadly genetic diseases based on data from a handful of patients, two of the ...

Dr. Céline Gounder, an internist, epidemiologist and infectious disease specialist, is a CBS News medical contributor as well as senior fellow and editor-at-large for public health at KFF Health News.

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Denver-based Tract is doubling ...

Researchers have identified a surprising cause of some urinary tract infections: contaminated meat. A four-year study found that nearly 1 in 5 UTIs detected among a group of patients in Southern ...

In recent years, hundreds of community colleges have embraced the guided pathways model, a sweeping set of large-scale reforms to better steer students through academic programs and boost completion ...

A new Georgetown University Medical Center study exploring a new brain imaging technique is bringing stroke experts a step closer to better tailoring rehabilitation. A new study by a global team of ...

Construction on the Able Canal shared-use pathway in Lehigh Acres kicks off today. Residents will notice flagging and staging at Lehigh Acres Park, but park activities will remain unaffected during ...

Health tech company Doximity bought Pathway Medical to bulk up its healthcare artificial intelligence capabilities as it looks to offer more free AI tools to doctors. The transaction closed July 29 ...

The cerebral cortex processes sensory information via a complex network of neural connections. How are these signals modulated to refine perception? A team from the University of Geneva (UNIGE) has ...

ITHACA, N.Y. – Psilocybin is the active ingredient that gives so-called “magic mushrooms” their hallucinogenic kick. It also has a therapeutic potential for treating depression. Now, Cornell ...